Lyra Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lyra Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • Lyra Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 65.5M shares, a 32.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 65.5M +15.9M +32.1% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 65.5M +15.9M +32.1% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 61M +29.1M +91.5% Mar 31, 2024 10-Q 2024-04-30
Q4 2023 57.2M +25.4M +79.8% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 49.5M +17.7M +55.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 49.5M +17.7M +55.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 31.8M +18.8M +145% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 31.8M +18.8M +145% Dec 31, 2022 10-K 2024-03-22
Q3 2022 31.8M +18.8M +145% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 31.8M +18.8M +145% Jun 30, 2022 10-Q/A 2022-11-02
Q1 2022 13M +47.1K +0.36% Mar 31, 2022 10-Q/A 2022-11-02
Q4 2021 13M +74.8K +0.58% Dec 31, 2021 10-K 2023-03-29
Q3 2021 13M +79.8K +0.62% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 13M +76.5K +0.59% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 13M +12.7M +5515% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 12.9M +12.7M +5502% Dec 31, 2020 10-K 2022-03-09
Q3 2020 12.9M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 12.9M Jun 30, 2020 10-Q 2020-08-05
Q1 2020 231K Mar 31, 2020 10-Q 2020-05-28
Q4 2019 231K Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.